Fundz

Belfast-Based Genome Raises £1.4 Million To Help With Earlier Detection Of Ovarian Cancer

PRIVATEMar 03, 2023

Amount Raised

£1.4 Million

Round Type

Seed

BelfastBiotechnologyHealth CareGeneticsTherapeuticsHealth Diagnostics

Investors

Anne DornanDr Mark Street DochertyDr Laura FeeneyStuart GaffikinDr Shannon BeattieChris MosedaleProf Paul MullanDeepbridge CapitalCo Fund NiQubis

Description

A Belfast-based spinout from the prestigious Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast, GenoME Diagnostics has raised £1.4 million in a pre-Series A round funding round

Quick answer

GenoME Diagnostics raised £1.4 Million in a Seed round, dated March 3, 2023. Investors: Anne Dornan, Dr Mark Street Docherty, Dr Laura Feeney, Stuart Gaffikin, Dr Shannon Beattie, Chris Mosedale, Prof Paul Mullan and Deepbridge Capital. GenoME Diagnostics is based in Belfast, Northern Ireland, United Kingdom.

How much did GenoME Diagnostics raise?
GenoME Diagnostics raised £1.4 Million in a Seed round on March 3, 2023.
Who invested in GenoME Diagnostics?
Anne Dornan, Dr Mark Street Docherty, Dr Laura Feeney, Stuart Gaffikin, Dr Shannon Beattie, Chris Mosedale, Prof Paul Mullan and Deepbridge Capital are named as investors in this round.
What does GenoME Diagnostics do?
GenoME Diagnostics is a new spinout from the prestigious Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast.
Where is GenoME Diagnostics based and how big is it?
GenoME Diagnostics is based in Belfast, Northern Ireland, United Kingdom.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as GenoME Diagnostics that raised within 45 days of this round, from Fundz verified event records.

  • Chroma Medicine raised $135M (Series B) on March 1, 2023.
  • Pathos AI raised $20M on February 17, 2023.
  • Chroma Medicine raised $135M on February 8, 2023.
  • TransCode Therapeutics raised an undisclosed amount on April 14, 2023.
  • Lapix Therapeutics raised $5.9M on April 14, 2023.
  • OncoLize raised $1.7M (Seed) on April 13, 2023.

Who to call at GenoME Diagnostics, and when

A new round usually means GenoME Diagnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GenoME Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GenoME Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GenoME Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GenoME Diagnostics

Location

Belfast, Northern Ireland, United Kingdom

About

GenoME Diagnostics is a new spinout from the prestigious Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast. We are developing a novel blood test for earlier and more accurate diagnosis of ovarian cancer and to improve upon the accuracy of the current gold standard ovarian cancer diagnostic test known as CA125; a test which is fraught with many inaccuracies. GenoME Diagnostics aims to reduce the misdiagnosis and late diagnosis associated with CA125 to improve patient survival and outcome. Our pipeline could be applied to biomarker discovery and development in a wide range of diseases and applications, which we plan to pursue, both in-house and for external parties.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GenoME Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for GenoME Diagnostics's next move

See what Strategic adds

GenoME Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.